Ghatge, M. ., Nair, J. ., Sharma, A. ., & Vangala, R. . (2018). Integrative gene ontology and network analysis of coronary artery disease associated genes suggests potential role of ErbB pathway gene EGFR. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2018.8393 (Original work published 2018)

Brill, E. ., Yokoyama, T. ., Nair, J. ., Yu, M. ., Ahn, Y. ., & Lee, J. . (2017). Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor, increases <i>in vitro</i> toxicity of PARP inhibition by preventing Rad51 foci formation in <i>BRCA</i> wild type high-grade serous ovarian cancer. Oncotarget, 8(67), 111026-111040. https://doi.org/10.18632/oncotarget.22195 (Original work published 2017)

Lee, J. ., Nair, J. ., Zimmer, A. ., Lipkowitz, S. ., Annunziata, C. ., Merino, M. ., … Kohn, E. . (2018). Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study. The Lancet. Oncology. https://doi.org/10.1016/S1470-2045(18)30009-3 (Original work published 2018)